124 related articles for article (PubMed ID: 16138507)
1. Preventing contrast-induced nephropathy: a basic solution.
Bridges JM; Feldstein DA
WMJ; 2005 Jul; 104(5):9-10. PubMed ID: 16138507
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
[TBL] [Abstract][Full Text] [Related]
3. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
[TBL] [Abstract][Full Text] [Related]
4. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
[TBL] [Abstract][Full Text] [Related]
5. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
7. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
Asher I; Hammerman A; Sthoeger Z
Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
[TBL] [Abstract][Full Text] [Related]
8. Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients?
Grossman PD; Burroughs M; Guthmann RA
J Fam Pract; 2005 Apr; 54(4):365-7. PubMed ID: 15833230
[TBL] [Abstract][Full Text] [Related]
9. Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate.
Barreto R
Nephrol Nurs J; 2007; 34(4):417-21. PubMed ID: 17891910
[TBL] [Abstract][Full Text] [Related]
10. Acetylcysteine to prevent acute contrast-induced nephropathy.
Mears JM
Am Fam Physician; 2004 Dec; 70(11):2077; author reply 2077. PubMed ID: 15606054
[No Abstract] [Full Text] [Related]
11. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
Budhiraja P; Chen Z; Popovtzer M
Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
[TBL] [Abstract][Full Text] [Related]
12. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
Huisman IA; Stegeman CA; Gans RO; Gansevoort RT
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2329-33. PubMed ID: 16261711
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
Kramers C; Wetzels J; Natsch S; ten Dam M
Ned Tijdschr Geneeskd; 2006 Feb; 150(5):274; author reply 275-6. PubMed ID: 16493996
[No Abstract] [Full Text] [Related]
15. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
16. Prevention of contrast-induced nephropathy by use of bicarbonate solution: preliminary results and literature review.
Silva RG; Silva NG; Lucchesi F; Burdmann EA
J Bras Nefrol; 2010; 32(3):292-302. PubMed ID: 21103694
[TBL] [Abstract][Full Text] [Related]
17. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
Cox CD; Tsikouris JP
J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
[TBL] [Abstract][Full Text] [Related]
18. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
19. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ
Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease.
Klarenbach SW; Pannu N; Tonelli MA; Manns BJ
Crit Care Med; 2006 Apr; 34(4):1044-51. PubMed ID: 16484907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
